2021. Combination therapy of omalizumab with house dust mite immunotherapy in chronic spontaneous urticaria associated with sensitization to dust mites-case series. Indian Journal of Case Reports. 7, 11 (Nov. 2021), 469–472. DOI:https://doi.org/10.32677/ijcr.v7i11.3107.